AAAAAA

   
Results: 1-10 |
Results: 10
Application of MS-WHIM descriptors: 1. Introduction of new molecular surface properties and 2. Prediction of binding affinity data
Authors: Bravi, G Wikel, JH
Citation: G. Bravi et Jh. Wikel, Application of MS-WHIM descriptors: 1. Introduction of new molecular surface properties and 2. Prediction of binding affinity data, QSAR, 19(1), 2000, pp. 29-38
Application of MS-WHIM descriptors: 3. Prediction of molecular properties
Authors: Bravi, G Wikel, JH
Citation: G. Bravi et Jh. Wikel, Application of MS-WHIM descriptors: 3. Prediction of molecular properties, QSAR, 19(1), 2000, pp. 39-49
Global 3D-QSAR methods: MS-WHIM and autocorrelation
Authors: Gancia, E Bravi, G Mascagni, P Zaliani, A
Citation: E. Gancia et al., Global 3D-QSAR methods: MS-WHIM and autocorrelation, J COMPUT A, 14(3), 2000, pp. 293-306
PLUMS: a program for the rapid optimization of focused libraries
Authors: Bravi, G Green, DVS Hann, MM Leach, AR
Citation: G. Bravi et al., PLUMS: a program for the rapid optimization of focused libraries, J CHEM INF, 40(6), 2000, pp. 1441-1448
Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors
Authors: Ekins, S Bravi, G Binkley, S Gillespie, JS Ring, BJ Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors, DRUG META D, 28(8), 2000, pp. 994-1002
Predicting drug-drug interactions in silico using pharmacophores: A paradigm for the next millennium
Authors: Ekins, S Ring, BJ Bravi, G Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Predicting drug-drug interactions in silico using pharmacophores: A paradigm for the next millennium, IUL BIOTECH, 2, 2000, pp. 269-299
Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors
Authors: Ekins, S Bravi, G Binkley, S Gillespie, JS Ring, BJ Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors, PHARMACOGEN, 9(4), 1999, pp. 477-489
Three-dimensional-quantitative structure activity relationship analysis ofcytochrome P-450 3A4 substrates
Authors: Ekins, S Bravi, G Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Three-dimensional-quantitative structure activity relationship analysis ofcytochrome P-450 3A4 substrates, J PHARM EXP, 291(1), 1999, pp. 424-433
Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors
Authors: Ekins, S Bravi, G Binkley, S Gillespie, JS Ring, BJ Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors, J PHARM EXP, 290(1), 1999, pp. 429-438
Three-dimensional quantitative structure activity relationship analyses ofsubstrates for CYP2B6
Authors: Ekins, S Bravi, G Ring, BJ Gillespie, TA Gillespie, JS Vandenbranden, M Wrighton, SA Wikel, JH
Citation: S. Ekins et al., Three-dimensional quantitative structure activity relationship analyses ofsubstrates for CYP2B6, J PHARM EXP, 288(1), 1999, pp. 21-29
Risultati: 1-10 |